"Since they are distinguished only by the time delay, revenue and cash receipts should indicate the same trend for sales growth."
In an ethical and properly conducted business that is the case. However we have seen instances of revenues being overstated through devious means but you can't fudge the cash figures.
As Taurean suggests receivables would be where you would look for an explanation of any major variation.
- Forums
- ASX - By Stock
- AN1
- 2018 - The Year of the BioTechs
2018 - The Year of the BioTechs, page-675
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable